Login to Your Account

New targets for overcoming melanoma resistance identified

By John Fox
Staff Writer

Tuesday, January 17, 2017

HONG KONG – A study by Japanese researchers has identified two promising and selective candidate therapeutic targets that could prove important in the development of new treatments aimed at overcoming drug resistance in melanoma. Drug resistance is a major problem in the treatment of melanoma patients, for example with drugs targeting BRAF-mutated melanomas such as Zelboraf.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription